Publications by authors named "Corrie Painter"

26Publications

COVID-19 and Cancer: Current Challenges and Perspectives.

Cancer Cell 2020 11 1;38(5):629-646. Epub 2020 Oct 1.

Cancer Program, Broad Institute of MIT and Harvard, 415 Main Street, Cambridge, MA 02142, USA. Electronic address:

View Article and Find Full Text PDF
November 2020

Crowdsourcing a crisis response for COVID-19 in oncology.

Nat Cancer 2020 Apr 21:1-4. Epub 2020 Apr 21.

9Division of Hematology and Medical Oncology, Department of Medicine, Miller School of Medicine, University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL USA.

View Article and Find Full Text PDF
April 2020

Identification and characterization of T reg-like cells in zebrafish.

J Exp Med 2017 Dec 24;214(12):3519-3530. Epub 2017 Oct 24.

Program in Molecular Medicine and Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, MA

View Article and Find Full Text PDF
December 2017

Emerging Opportunities for Target Discovery in Rare Cancers.

Cell Chem Biol 2017 Sep;24(9):1075-1091

Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA. Electronic address:

View Article and Find Full Text PDF
September 2017

Zebrafish as a platform to study tumor progression.

Methods Mol Biol 2014 ;1176:143-55

Program in Molecular Medicine, Department of Cancer Biology, Program in Cell and Developmental Dynamics, University of Massachusetts Medical School, 368 Plantation Street, Worcester, MA, 01605, USA.

View Article and Find Full Text PDF
March 2015

HLA-DO acts as a substrate mimic to inhibit HLA-DM by a competitive mechanism.

Nat Struct Mol Biol 2013 Jan 9;20(1):90-8. Epub 2012 Dec 9.

Department of Pathology, University of Massachusetts Medical School, Worcester, Massachusetts, USA.

View Article and Find Full Text PDF
January 2013

Conformational variation in structures of classical and non-classical MHCII proteins and functional implications.

Immunol Rev 2012 Nov;250(1):144-57

Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, USA.

View Article and Find Full Text PDF
November 2012

Conformational lability in the class II MHC 310 helix and adjacent extended strand dictate HLA-DM susceptibility and peptide exchange.

Proc Natl Acad Sci U S A 2011 Nov 14;108(48):19329-34. Epub 2011 Nov 14.

Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA 10655, USA.

View Article and Find Full Text PDF
November 2011

Structural Insights Into HLA-DM Mediated MHC II Peptide Exchange.

Curr Top Biochem Res 2011 ;13(2):39-55

Department of Biochemistry and Molecular Pharmacology and Department of Pathology, University of Massachusetts Medical School, Worcester, MA 01655 USA.

View Article and Find Full Text PDF
January 2011

Model for the peptide-free conformation of class II MHC proteins.

PLoS One 2008 Jun 11;3(6):e2403. Epub 2008 Jun 11.

Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America.

View Article and Find Full Text PDF
June 2008

Acute tissue-type plasminogen activator release in human microvascular endothelial cells: the roles of Galphaq, PLC-beta, IP3 and 5,6-epoxyeicosatrienoic acid.

Thromb Haemost 2007 Feb;97(2):263-71

Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232-6300, USA.

View Article and Find Full Text PDF
February 2007

Noble metals strip peptides from class II MHC proteins.

Nat Chem Biol 2006 Apr 26;2(4):197-201. Epub 2006 Feb 26.

Institute of Chemistry and Cell Biology, Harvard Medical School, 200 Longwood Ave., Boston, Massachusetts 02115, USA.

View Article and Find Full Text PDF
April 2006

Tumor necrosis factor alpha activates the human plasminogen activator inhibitor-1 gene through a distal nuclear factor kappaB site.

J Biol Chem 2004 Apr 12;279(18):18127-36. Epub 2004 Feb 12.

Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee 37232-6300, USA.

View Article and Find Full Text PDF
April 2004

Regulation of the PAI-1 promoter by circadian clock components: differential activation by BMAL1 and BMAL2.

J Mol Cell Cardiol 2003 May;35(5):473-81

Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, 2220 Pierce Avenue, 383 PRB, Nashville, TN 37232, USA.

View Article and Find Full Text PDF
May 2003

ACE inhibition versus angiotensin type 1 receptor antagonism: differential effects on PAI-1 over time.

Hypertension 2002 Dec;40(6):859-65

Division of Clinical Pharmacology, Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN 37232-6602, USA.

View Article and Find Full Text PDF
December 2002